Navigation Links
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Date:11/5/2011

ysician office visits, laboratory services, and ancillary services than patients in the control group without tophi or gout flares (p<0.001). A comparison of patient records revealed that total 12-month costs averaged $21,059 among patients with tophi and greater than or equal to 3 gout flares compared to $10,657 for patients in the control group (p<0.001). In addition, patients with tophi and greater than or equal to 6 gout flares had even higher resource utilization and overall healthcare costs totaling $32,178 compared to the control group (p<0.01).

"The gout epidemiology data presented at the ACR meeting underscore the importance of initiating early treatment with the appropriate medication to minimize the mental, physical and economic impact of gout and refractory chronic gout," commented Herbert S. B. Baraf, M.D., Clinical Professor of Medicine at The George Washington University School of Medicine and an investigator who conducted clinical trials with KRYSTEXXA. "Recently published data demonstrated that treatment with KRYSTEXXA resulted in significant and sustained reductions in uric acid levels and clinical improvements in RCG patients. The data from the post-hoc analysis of the KRYSTEXXA pivotal and extension studies will add to physicians' knowledge of the treatment and provide them with a straightforward approach for managing the risk of potential infusion reactions."

ABOUT THE STUDIESComplete abstracts can be found online via the following links:

Characterization and Management of Infusion Reactions in Refractory Chronic Gout (RCG) Treated with Pegloticase (KRYSTEXXA)
Presentation Number: 2582
Wednesday, November 9, 2011: 9:45 AM
Oral presentation W 474 A (McCormick Place Convention Center)

Patient Management/Treatment and Outcomes of Gout Between Primary Care P
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
2. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
3. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
4. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
5. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
6. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
7. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
8. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
9. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
10. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
11. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 The new 13-valent ... as the previous version used prior to 2010, the ... Permanente study published today in Vaccine. The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
(Date:5/22/2013)... YORK , May 22, 2013 ... LLP is investigating claims on behalf of investors of ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive ... 18, 2013 (the "Class Period"). Such investors are advised ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
(Date:5/23/2013)... May 23, 2013 Footwear etc. is pleased ... Vista Collection of sandals containing cork footbeds. Known for its ... consistently good sales for many years, and with this new ... summer. , Dansko Shoes and Sandals are ... Collection is no exception. Containing leather and patent leather uppers ...
(Date:5/23/2013)... May 23, 2013 Following the recent ... UK internet users, the security team at idcloak Technologies ... safeguards against this or any web-born malware. Gill-Chris ... technology provides far better privacy and security ... underlined that even the best AV software cannot be ...
(Date:5/23/2013)... 2013 Long-Term Care Insurance shopping ... rate at which applicants for Long Term Care Insurance are ... , The decision to buy a Long Term Care ... willing and able to purchase protection are increasingly being turned ... any price. A variety of chronic conditions appear to ...
(Date:5/23/2013)... 2013 When Teachers Notebook reached out ... raise funds for the Moore, OK tornado victims, they ... items that could be sold for around $10.00 with ... at Teachers Notebook were overwhelmed by the response from ... of materials within the first 12 hours of the ...
(Date:5/23/2013)... 2013 AttorneyOne.com, a recognized authority on ... actively providing expert opinion in view of the recent ... According to court documents, on March 5, 2013 a ... (case no. 3:2013cv50102) alleging that her husband suffered massive ... Pharmaceuticals, is mainly used as a blood thinner for ...
Breaking Medicine News(10 mins):Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2
... ... chairman of the board of directors for PerfectServe, a clinical communications company currently serving ... ... Gene Barduson was recently named executive chairman of the board of directors for ...
... , , BOCA RATON, ... the market leader in all-natural herbal and homeopathic remedies for ... as their PR firm of record. The company,s two brands, ... provide complete lines of safe, scientifically-tested, guaranteed products that promote ...
... AllegroMedical.com partners with ... ... help find a cure for spinal cord injury: The online retailer of medical supplies ... is a forward-thinking manufacturer of catheters. In an effort to facilitate finding a cure ...
... more emotional and behavioral difficulties when compared to other ... most when a parent is deployed overseas, according to ... having a parent deployed for a longer period of ... with emotional problems were important factors associated with whether ...
... , , Consumers ... SILVER SPRING, Md., Dec. 6 The U.S. Food and Drug ... San Antonio Bay on or after Nov. 16 due to reports ... from this area, which is located on the Gulf of Texas. ...
... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ...
Cached Medicine News:Health News:Gene Barduson Named Chairman of PerfectServe Board of Directors 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: